A world-first clinical trial will test cancer vaccines designed specifically for children with advanced or treatment-res...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and Samsung Biologics, a South Korea-based contract ...
South Korea-based SK bioscience has announced that it is advancing the development of a Zaire ebolavirus vaccine under a...
SK bioscience has announced the new domestic launch of MenQuadfi Injection (MenQuadfi, MenACWY-TT), a quadrivalent menin...
Researchers from the Department of Bio and Brain Engineering at Korea Advanced Institute of Science and Technology (KAIS...
French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...
Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted a licence by the Therapeutic Goods Administration...
Leading scientific organisations in Korea including the Korea Disease Control Agency (KDCA), International Vaccine Insti...
Australia’s onshore vaccine manufacturing capabilities took a leap forward as Mark Butler MP, Minister for Health,...
The Japanese Foundation for Cancer Research (JFCR), NEC Corporation, and Taiho Pharmaceutical Co. have signed a three-pa...
Singapore-based startup Patronus Biotech has announced a grant from the Gates Foundation to accelerate the development o...
Sanofi and AstraZeneca's Beyfortus (Nirsevimab) is now approved (KKLIU 3697 / EXP 16.05.2026) by the National Pharmaceut...
A new intranasal influenza vaccine has been launched in Singapore, offering a needle-free option for individuals aged ...
US-based Apriori Bio and Singapore's Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) h...
Australia’s new national incubator for vaccine and infectious disease innovation, Biointelect Venturer, has been l...
Nearly a decade after the world’s attention was gripped by the Zika virus outbreak in Brazil, the disease is quiet...
HPV and PCV are the leading vaccines in the self-paid market in China. According to the WHO vaccine market report 2024, ...
The vaccine landscape in Asia-Pacific is undergoing significant transformation and growth. While public-sector programme...
Australia-based CSL Seqirus and Vaccine Industrial Company have signed a Memorandum of Understanding with the Ministry o...
One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as Nor...
France-based Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based prod...
GC Biopharma, a South Korean biopharmaceutical company, has signed an agreement with Curevo Vaccine to secure contract m...
Professor Shawn Chen Xiaoyuan, Nasrat Muzayyin Professor in Medicine and Technology from the Department of Dia...
The Zambia National Public Health Institute (ZNPHI) and South Korea-based International Vaccine Institute (IVI) has sign...
Josephine Cheng, Senior Modality Leader, Process Solutions, Life Science Business of Merck The global pharmaceutic...
Australian children will now have stronger protection against pneumococcal with the Australian Government implementing a...
Australia-based Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for need...
Australian biotech firm CSL has announced its intention for CSL Seqirus to be demerged as a substantial ASX-listed entit...
The Health Sciences Authority (HSA) has approved Sanofi and AstraZeneca’s BEYFORTUS (nirsevimab) for the preventio...
Two leading scientific organisations based in Korea, the Korea Disease Control and Prevention Agency (KDCA) and Int...
Scientists have launched the first-ever library of adjuvants - substances that could boost the performance of vaccines t...
South Korea-based Dx&Vx (DXVX) has signed its first-ever global out-licensing agreement since its establishment. DXV...
The Bhutan-International Vaccine Institute (IVI) Collaborating Centre has been officially launched in Thimphu, Bhutan, m...
Sanofi has entered into an agreement to acquire Vicebio Ltd, a privately held biotechnology company headquartered in Lon...
Australian scientists will kickstart research into how early vaccine studies can safely support faster approvals of vacc...
Eyam Health and Medicines for Malaria Venture (MMV) are excited to announce a strategic research partnership to discover...
Chengdu Kanghua Biological Products Co. has announced that Shanghai Healthcare M&A Fund intends to acquire the compa...
GC Biopharma, a South Korean pharmaceutical company, has announced that its varicella vaccine BARYCELA has received mark...
(From Left to Right) Professor Kouichi Morita, Dean, Program Coordinator, Institute of Tropical Medicine, Nagasaki Un...
The Bio Investments Group AG (BIG), a Swiss healthcare-technology transfer platform, and South Korea-headquartered Inter...
Jiangsu Recbio Technology, a leading Chinese biopharmaceutical company, has entered into a licensing cooperation agreeme...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has secured a large-scale co...
Singapore has pledged a contribution of $1 million to Gavi, the Vaccine Alliance (Gavi). This reflects Singapore&rsquo...
CanSino Biologics Inc. has developed and launched its 13-valent pneumococcal conjugate vaccine, trade name "iPneucia", o...
Immuno Cure BioTech, a clinical-stage biotechnology startup based in Hong Kong Science Park, has announced its upcoming ...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhab...
BioNet, a Franco-Thai vaccine biotech group, and PT Bio Farma (Persero), Indonesia's state-owned vaccine manuf...
What trends are shaping the next generation of vaccine manufacturing in the Asia-Pacific (APAC) region? Traditional vac...
An unenviable challenge for many countries in the APAC region seeking to establish sovereign capability, is the brain dr...
Bio-healthcare company Dx&Vx (DXVX) has accelerated the development program for a universal COVID-19 vacci...
VNVC Vaccine and Biological Products Factory in Long An Province, in southern Vietnam, has begun construction on i...
Sanofi and Vietnam Vaccine JSC, or VNVC, launched a project on 27 May to establish vaccine manufacturing facility in...
CanSino Biologics Inc, based in China, has obtained clinical trial approval from the Badan Pengawas Obat danMakanan, Rep...
US-based TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and s...
New research led by a team of scientists in Singapore will explore whether a novel targeted delivery platform could help...
As an infectious diseases’ physician, clinical researcher and microbiologist, I have seen first-hand how new techn...
South Korea-based International Vaccine Institute (IVI) in collaboration with International Centre for Antimicrobial Res...
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cu...
How has vaccine manufacturing capacity evolved in the Asia-Pacific region over the past decade? Over the past decade, I...
How has vaccine manufacturing capacity evolved in the Asia-Pacific region over the past decade? Over the past decade, v...
Asia-Pacific is driving a transformation in the global vaccine supply landscape. According to the WHO Vaccine Report 202...
The British Embassy in Korea, the British Chamber of Commerce in Korea, and GSK Korea have signed a three-way Memorandum...
Minister of Health Dao Hong Lan in Vietnam recently received a delegation led by Burak Pekmezci, Country Lead of Sanofi-...
Australia's Queensland researchers are attempting to create a vaccine in just 150 days to prove how far their response c...
GC Biopharma has announced that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine...
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for...
Efforts to advance the first-ever vaccine against Middle East Respiratory Syndrome (MERS) are progressing, with a new in...
The World Vaccine Congress Washington 2025, the largest and most influential global vaccine event, is officially open fo...
Japan's Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 1.7 b...
US-based PharmaJet, a company that strives to improve the performance and outcomes of injectables with its enabling...
South Korea-based SK bioscience, a global innovative vaccine and biotech company committed to promoting human health fro...
South Korea-based SK bioscience had received prior notification from the Pan American Health Organization (PAHO), a spec...
The Asia Pacific Immunization Coalition (APIC) and the Asia Dengue Voice & Action (ADVA), with the Centre for Behavi...
South Korea-based SK bioscience, and global healthcare leader Sanofi, are strengthening their partnership to jointly tar...
Vaxxas, an Australia-based clinical-stage biotechnology company commercialising a novel high-density microarray patch (H...
Asia is emerging as a hub for biopharmaceuticals and vaccine manufacturing, leveraging its strengths in manufacturing an...
Australia-based University of Queensland’s (UQ) BASE facility, within the Australian Institute for Bioenginee...
In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an I...
South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...
Scientists from Australia's Biomedical Manufacturing Programme are partnering with Thailand and Malaysia to en...
A research consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to und...
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...
Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...
Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...
The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...
Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...
Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...
SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...
China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...
South Korea-based SK bioscience has signed an agreement to acquire a stake in Fina Biosolutions, a promising R&D bio...
Moderna, Inc. and Cenra Healthcare, the sales and marketing arm of Cenra Inc., have entered into a joint agreement regar...
Singapore Health Sciences Authority (HSA) has approved the Pfizer's bivalent vaccine, Abryvso, for active immu...
The World Health Organization (WHO) has announced MVA-BN vaccine as the first vaccine against mpox to be added to its pr...
Global biotechnology leader CSL and self amplifying-mRNA pioneer Arcturus Therapeutics have announced that Japan's Minis...
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) has announced the launch of its Herpes Zoster vaccine, Shingrix, ...
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition o...
